The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Pacira BioSciences Inc shares valued at $397,877 were sold by Cross Shawn on Dec 09 ’25. At $25.03 per share, Cross Shawn sold 15,896 shares. The insider’s holdings dropped to 56,250 shares worth approximately $1.46 million following the completion of this transaction.
Also, Cross Shawn sold 9,104 shares, netting a total of over 228,875 in proceeds. Following the sale of shares at $25.14 each, the insider now holds 56,250 shares.
Before that, Cross Shawn had added 9,104 shares to its account. In a trade valued at $228,912, the Officer bought Pacira BioSciences Inc shares for $25.14 each.
As published in their initiating research note from Barclays on December 09, 2025, Pacira BioSciences Inc [PCRX] has been an Equal weight and the price target has been revised to $27. Analysts at H.C. Wainwright started covering the stock with ‘”a Buy”‘ outlook in a report released in mid November. As of July 25, 2025, Truist has increased its “Hold” rating to a “Buy” for PCRX. Earlier on January 30, 2025, Truist upgraded its rating. Their new recommendation was “a Hold” for PCRX stock which previously was a “a Sell”.
Analyzing PCRX Stock Performance
On last trading session, Pacira BioSciences Inc [NASDAQ: PCRX] plunged -0.73% to $25.88. The stock’s lowest price that day was $25.845, but it reached a high of $26.365 in the same session. During the last five days, there has been a surge of approximately 0.54%. Over the course of the year, Pacira BioSciences Inc shares have jumped approximately 31.70%. Shares of the company reached a 52-week high of $27.64 on 09/03/25 and a 52-week low of $18.17 on 01/06/25.
Support And Resistance Levels for Pacira BioSciences Inc (PCRX)
According to the 24-hour chart, there is a support level at 25.69, which, if violated, would cause prices to drop to 25.51. In the upper region, resistance lies at 26.22. The next price resistance is at 26.55. RSI (Relative Strength Index) is 56.51 on the 14-day chart, showing neutral technical sentiment.
Is Pacira BioSciences Inc subject to short interest?
Stocks of Pacira BioSciences Inc saw a sharp rise in short interest on 2025-12-15 jumping by 67479.0 shares to 7.34 million. Data from Yahoo Finance shows that the short interest on 2025-11-14 was 7.28 million shares. A jump of 0.92% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 9.53 of the overall float, the days-to-cover ratio (short ratio) jumped to 9.53.
Which companies own the most shares of Pacira BioSciences Inc (PCRX)?
In terms of Pacira BioSciences Inc share price expectations, FactSet research, analysts set an average price target of 27 in the next 12 months, up nearly 3.57% from the previous closing price of $26.07. Analysts anticipate Pacira BioSciences Inc stock to reach 27 by 2026, with the lowest price target being 27. In spite of this, 6 analysts ranked Pacira BioSciences Inc stock as Buy at the end of 2026. On August 13, 2024, Truist assigned a price target of “a Sell” to the stock and downgraded coverage with a $8.
